Molecule could help treat insulin resistance

Diabetes Call for further research into apelin treatment in diabetes after positive results in mice.

Insulin resistance in diabetes and other metabolic disorders could be treated by a naturally occurring molecule with insulin-like effects, studies by French researchers suggest.

The mechanisms that regulate apelin, a peptide found in a variety of tissues in the body and in the bloodstream, and those that regulate insulin are known to be closely related, but researchers had not previously looked at how apelin affects glucose metabolism in the body.

Professor Isabelle Castan-Laurell and colleagues from the University of Toulouse injected mice intravenously with apelin and found that it rapidly reduced glucose levels in the blood.

They then went on to examine how apelin affected the way that glucose was metabolised in the body. They found that apelin increased glucose turnover and, in response, liver tissue adjusted its glucose production so that normal blood glucose levels were maintained.

In addition, apelin was able to increase insulin-stimulated glucose transport, suggesting that the effects of apelin and insulin are mediated by different mechanisms and can be additive.

'Apelin could represent a promising target in the management of insulin resistance,' Professor Castan-Laurell said.

'Improvement of insulin sensitivity and reduction of blood glucose levels are expected goals for the treatment of type-2 diabetes. We demonstrated that acute injection of apelin was able to improve glucose tolerance in insulin-resistant mice and to increase glucose utilisation in white adipose tissue, skeletal muscles and the heart.'

The effect of long-term treatment with apelin will now need to be studied to provide further insight into the precise role the peptide plays in treating insulin resistance, the researchers said.

The findings may also have wider benefits, they pointed out. 'The contribution of apelin should yield new insights into the physiology and physiopathology of glucose and lipid metabolism.'

tom.moberly@haymarket.com

Cell Metabolism 2008; 8: 437-45

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP training: Working remotely as a GP trainee during the pandemic

GP training: Working remotely as a GP trainee during the pandemic

Dr Zoe Brown was in her first year of GP training and pregnant as lockdown began....

GPs warn government off PCN-led test and trace system

GPs warn government off PCN-led test and trace system

GPs have rebuffed suggestions that primary care networks (PCNs) are ‘best placed’...

Map: Three-fold variation in GP practice list size between CCGs

Map: Three-fold variation in GP practice list size between CCGs

The list size of GP practices across England has grown rapidly over the past decade...

Advance decisions to refuse treatment - what GPs need to know

Advance decisions to refuse treatment - what GPs need to know

A recent case has underlined the need for GPs to communicate a patient’s known wishes...

Law changed to allow physios and paramedics to administer vaccines during pandemic

Law changed to allow physios and paramedics to administer vaccines during pandemic

A wider range of healthcare workers will be allowed to administer flu and potential...

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages in England are continuing to drive up GP workload during the...